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The dense innervation of the gastro-intestinal tract with neuronal networks, which are
in close proximity to immune cells, implies a pivotal role of neurons in modulating
immune functions. Neurons have the ability to directly sense danger signals, adapt
immune effector functions and integrate these signals to maintain tissue integrity and
host defense strategies. The expression pattern of a large set of immune cells in the
intestine characterized by receptors for neurotransmitters and neuropeptides suggest
a tight neuronal hierarchical control of immune functions in order to systemically
control immune reactions. Compelling evidence implies that targeting neuro-immune
interactions is a promising strategy to dampen immune responses in autoimmune
diseases such as inflammatory bowel diseases or rheumatoid arthritis. In fact, electric
stimulation of vagal fibers has been shown to be an extremely effective treatment strategy
against overwhelming immune reactions, even after exhausted conventional treatment
strategies. Such findings argue that the nervous system is underestimated coordinator
of immune reactions and underline the importance of neuro-immune crosstalk for body
homeostasis. Herein, we review neuro-immune interactions with a special focus on
disease pathogenesis throughout the gastro-intestinal tract.
Keywords: neuro-immune interactions, chronic inflammatory diseases, autonomous nervous system, enteric
nervous system (ENS), tissue homeostasis
INTRODUCTION
Immune responses at mucosal barriers are of particular interest because the mucosa is the primary
entry port for many pathogens as well as the major site for chronic and sometimes detrimental
immune responses. The interaction between the immune and the nervous system at mucosal
barriers is attractingmore attention from researchers worldwide. Recent advances in understanding
the role of the interplay between both systems have uncovered a pivotal role of the nervous
system in modulating immune responses and vice versa. The notion that the immune system
and the nervous system share many commonalities emerged the idea of strong cross-interactions
(1). Evolutionary similarities, such as signaling via transmitters, information delivery to distant
body regions and migratory behavior, link the nervous with the immune system and together they
coordinate the integration of danger signals to external environmental stimuli (1). The nervous
system per se is a large interface that is strongly involved in maintaining body homeostasis (2).
On the one hand, autonomic neurons sense a broad variety of parameters such as mechanical
distortion, physicochemical attributes, secretions, nutrients and toxins (3). On the other hand,
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the autonomic nervous system controls effector functions such
as intestinal motility, blood flow, and secretory functions (4).
Specifically, the enteric nervous system (ENS) controls and
dictates the motor function of smooth muscle cells throughout
the gastrointestinal tract. Such coordinated muscular activity
results in squirting of ingested food, allows for mixing with
digestive enzymes and eventually commands the aboral transport
of non-digestible products (5). Of note, the intestine is densely
innervated by the autonomous nervous system and populated
by hematopoietic cells, therefore providing opportunities for
neuro-immune interactions (4). Advances in the understanding
of neuro-immune interactions has uncovered the immune-
modulatory properties of neurons and emerged an interesting
treatment approach for inflammatory conditions (6).
Current treatment modalities for autoimmune diseases, such
as inflammatory bowel diseases (IBD), are often insufficient.
These therapies target specific molecules on the surface of
immune cells or, more general, dampen immune responses.
However, this strategy fails to control disease-activity in many
patients (7). There is strong evidence that modulation of the
autonomic nervous system can exert strong anti-inflammatory
effects, even after exhausted therapeutical modalities (8, 9).
Current biologics targeting immune cells for example in IBD
are often insufficiently effective and associated with severe side
effects (10). There is a strong need for novel therapeutics with low
side effects that have immune-modulatory functions rather than
solely dampening effector functions. Thus, treatment strategies
that harness neuro-immune interactions may be a promising
approach because it is known that the nervous system is able
to exert strong anti-inflammatory effects in mice and humans
(9, 11). Herein, we review current knowledge in neuro-immune-
interactions that maintain body homeostasis with a special focus
on disease entities and the translational relevance as a potential
therapeutic target in inflammatory diseases within the intestine.
ANATOMICAL ORGANIZATION OF THE
AUTONOMOUS NERVOUS SYSTEM
The term “gut-brain-axis” illustrates the bidirectional
communication between the central nervous system (CNS)
and the intestine that includes the autonomous nervous and
the neuroendocrine system via the hypothalamic-pituitary-
adrenal-axis. The autonomous nervous system provides an
anatomical cue connecting the CNS with the peripheral tissues
(Figure 1). Generally, the innervation of tissues can be classified
as intrinsic, if the neuron’s cell body lies within the respective
tissue and extrinsic, if the cell body of the neuron is located
outside the tissue (Figure 2) (12). The ENS belongs together
with the sympathetic and parasympathetic nervous system
to the autonomous nervous system. Even though the ENS
receives input from the CNS, it largely functions independently
suggesting a hierarchical structural organization. As a matter of
fact, the majority of neurons in the vagal nerve are afferent and
thus transmit signals from the intestine to the CNS suggesting
that the brain is rather a signal receiver that perceives and
integrates signals arising from the gut in order to quickly
react to potential danger, damage, or threat (13). The pivotal
role of the ENS is highlighted in Hirschsprung’s disease, a
disorder characterized by congenital lack of enteric neurons. The
consequential lack of coordinated propulsive motility pattern in
the colon mediated by the ENS results in high morbidity and
mortality (14). The crucial role of the ENS for body homeostasis
is also illustrated in enteric infections that affect enteric neurons,
such as in Chagas disease, which may cause acquired loss of
enteric neurons resulting in megaviscera with potential life
threatening complications (15).
The ENS is organized in afferent/sensory neurons that
transfer information to the CNS, and efferent/motor neurons
that transmit signals from the CNS to the periphery.
Upon stimulation, somatosensory information is further
processed/integrated by dorsal root ganglia located in proximity
to the spinal cord. The effector function of the nervous system
can be categorized into a somatic and an autonomous arm.
The somatic efferent system originates from the brainstem and
spinal cord and forms motor neurons that innervate skeletal
muscles. The effector function of the somatic neuronal system
can be consciously controlled. The autonomous nervous system
on the other hand is largely independent of CNS control and
can be further subdivided into the sympathetic nervous system,
parasympathetic nervous system and ENS (Figure 1, right
vs. left panel). The sympathetic and parasympathetic nervous
system are anatomically distinct and in many aspects designed
to be biochemical and functional counter players (16). The
conserved function of sympathetic neurons is to elicit a fight-
or-flight reaction, whereas parasympathetic neurons activate a
rest-and-digest reaction. The cell bodies of the preganglionic
neurons from the sympathetic nervous system are localized in
the thoraco-lumbar region, which receive input from the brain
stem, hypothalamus and the formation reticularis. Preganglionic
sympathetic neurons synapse with postganglionic neuron
located in the latero-dorsal thoracolumbar region, which is
also referred to as sympathetic trunk. After signal transmission,
the long postganglionic sympathetic neurons innervate the
gastro-intestinal tract and maintain tissue homeostasis. The cell
bodies of parasympathetic preganglionic neurons on the other
hand are located in the brainstem and the pelvic sacral nerves.
Similar to the sympathetic, the parasympathetic nervous system
transmits signals from the brainstem to the respective organs
via two neurons. However, the postganglionic parasympathetic
neurons are localized in immediate proximity to the target organ.
The parasympathetic nervous system innervates the gastro-
intestinal tract with nerve fibers from the vagal nerve that end
just before the splenic flexure of the transverse colon (also known
as Cannon’s point) and afterwards with fibers originating from
pelvic sacral nerves. Both, the sympathetic and parasympathetic
preganglionic neurons are cholinergic and predominantly
express and secrete the neurotransmitter acetylcholine (Figure 1;
neurotransmitters highlighted in red/green/yellow). The
parasympathetic postganglionic neurons are also cholinergic
whereas the sympathetic postganglionic sympathetic neurons
are catecholaminergic and predominantly express and secrete
norepinephrine as a neurotransmitter. The identification of the
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FIGURE 1 | Anatomical organization of the autonomous nervous system. The autonomous nervous system is organized in three anatomical and biochemical distinct
systems. (1) The sympathetic nervous system has its preganglionic cell bodies in the thoraco-lumbar region (sympathetic trunk). The pregangliotic sympathetic
neurons synapses with the postgangionic neuron in the sympathetic trunk, whereas the long postganglionic neuron (red) innervates the respective part of the
gastro-intestinal tract. (2) The cell bodies of the parasympathetic nervous system are located in the brainstem and the pelvic sacral nerves. The vagal nerve includes
preganglionic fibers from parasympathetic nervous system (green) that innervates the gastro-intestinal tract and ends just before the splenic flexure of the transverse
colon (also known as Cannon’s point). After Cannon’s point, the colon is innervated by the pelvic sacral plexus. The postganglionic neuron is localized in immediate
proximity to the target organ. (3) The enteric nervous system is located within intestinal tissues (Auerbach plexus, Meissner plexus) and has a characteristic
architecture (details see Figure 2).
respective neuronal subsets is therefore based on the expression
of enzymes involved in neurotransmitter synthesis such as
tyrosine hydroxylase for sympathetic catecholaminergic neurons
and choline acetyltransferase (Chat) for parasympathetic
cholinergic neurons (17). Because many different immune
cells express the receptor for norepinephrine, such as α- and
β-adrenoreceptors, the sympathetic nervous system is tightly
linked to immune regulation (18). Potentially as a part of
the fight-and-flight reaction that need to ensure survival of
the organism, the sympathetic nervous system initially has a
pro-inflammatory function (19). In long term, the sympathetic
nervous system rather suppresses inflammation via β-adrenergic
receptors expressed on Neutrophils, Macrophages, innate
lymphoid cells (ILCs) and other immune cells (20–25). The exact
response of catecholamines, however, is also context-dependent
for example on environment and local challenges, co-stimulatory
factors and activation levels of cells (19). The parasympathetic
nervous system acts via secretion of acetylcholine, which
binds to muscarinic and nicotinic acetylcholine receptors. In
general, acetylcholine has a rather anti-inflammatory effect
following activation. This can be observed upon stimulation
of the vagal nerve, which has been termed the “cholinergic
anti-inflammatory reflex” (26). Apart from controlling vegetative
functions, acetylcholine and norepinephrine regulate cytokine
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FIGURE 2 | Schematic representation of the enteric nervous system (ENS) in the intestine. The myenteric plexus (Auerbach plexus) lies within the longitudinal and the
circular muscle layer, whereas the submucosal plexus (Meissner plexus) is located below the circular muscle layer. The transverse view of the intestinal wall shows the
cellular composition of the ENS including neurons and glial cells. The innervation of the ENS is classified as intrinsic, if the neuron’s cell body lies within the intestinal
wall and extrinsic, if the cell body of the neuron is located outside the intestinal wall.
secretion of hematopoietic cells. Vice versa, neurons express
cytokine receptors to adequately react on inflammatory stimuli
(27). The effect of autonomic innervation of lymphoid organs
has been highlighted in the spleen, which is innervated by the
superior mesenteric ganglion and eventually the splenic nerve
(Figure 1). Especially in the white pulp, T- and B-cell as well as
macrophages are in close contact with neuronal innervation (28).
Functionally, the interaction of the autonomous nervous system
and immune cells control local and systemic inflammation
via the cholinergic anti-inflammatory pathway (26). This anti-
inflammatory pathway originates anatomically from the vagal
nerve that innervates abdominal organs and controls the release
of its predominant neurotransmitter acetylcholine. Activation of
the vagal nerve lowers the systemic inflammatory response via
inhibition of TNF production by myeloid cells (29).
The ENS is organized in plexuses throughout the intestine
composed of neurons whose cell bodies lie within the intestinal
wall (Figure 2). It forms a continuous modality and ranges
from the upper esophagus to the internal anal sphincter. The
ENS is the largest accumulation of neurons outside the CNS
and contains 100 to 500 million neurons and is thus referred
to as the “abdominal brain” (30, 31). The myenteric plexus
(Auerbach plexus) lies between the longitudinal and circular
muscle layer in the intestinal wall whereas the submucosal
plexus (Meissner plexus) forms a network within the submucosal
layer (Figure 2). The ENS forms a dense network that mainly
includes neurons and glial cells and controls peristalsis, blood
flow and maintains water and electrolyte homeostasis. Neurons
in the ENS can be categorized based on their anatomy, function
and neurotransmitter signature. Up to 20 functional classes of
neurons can be identified in the guinea pig. Functionally and
phenotypically, several types of enteric neurons are distinguished
and can be further sub-classified: Excitatory neurons innervating
intestinal muscles, inhibitory neurons innervating intestinal
muscles (to circular and longitudinal muscles, respectively),
secretomotor and vasodilator neurons, secretomotor neurons
without vasodilator activity and neurons to enteroendocrine
cells, sensory intrinsic primary afferent neurons, ascending and
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descending interneurons and intestinofugal neurons (32–34).
Single-cell sequencing experiments revealed nine clusters of
enteric neurons in mice, which can be classified based on
the two neurotransmitters nitric oxide (NO) (Nos1 expression,
cluster 1–3) and acetylcholine (Chat expression, cluster 4–
9) (35). Structurally, Nos1+ neurons are preferentially type
I neurons whereas among Chat+ neurons type II neurons
are overrepresented (34). Additional neurotransmitters include,
gamma-Aminobutyric acid (GABA), epinephrine and dopamine,
but also vasoactive intestinal peptide (VIP), neuromedin U
(NMU), calcitonin gene-related peptide (CGRP), Substance P,
Galanin, Tachykinin, and others (32, 35).With regard to neuronal
regulation of immune responses, the biochemical signature of
the neuron (neurotransmitters, neuropeptides) appear to be
functionally most relevant, since many of the neuropeptides such
as VIP, NMU, CGRP regulate immune responses via different
subsets of immune cells (36–44). The in-depth characterization
of enteric neurons may allow to identify neuronal subsets based
on the expression of neurotransmitters/neuropeptides and to
assign specific inflammatory functions analog to immune cells.
However, how the immune modulatory function of neuronal
factors is linked to their physiological function is still poorly
understood. Such insights would provide an integrated view
on the regulation of intestinal and immune homeostasis. For
example, it is well-established that inhibitory motor neurons
in the ENS are characterized by co-expression of NO and
VIP as main neurotransmitters (34, 35). However, how the
inhibition of motor activity is linked to regulation of immune
cells and what are the respective stimuli for their release remains
poorly understood.
NEURONAL AFFERENT SIGNALS
MODULATE TISSUE IMMUNITY
Sensory neurons play an important role in detecting harmful
environmental challenges, transmit these signals to the CNS
and allow for an adequate reaction against potential pathogenic
threats or tissue damage. Recent evidence suggests that the CNS
receives direct neuronal afferent signals upon the input from
gut enteroendocrine sensory cells. Enteroendocrine cells are gut
epithelial cells that form a tight connection with vagal neurons.
This interaction builds the basis of a neuro-epithelial circuit
to the CNS that senses gut stimuli via glutamate as the main
neurotransmitter (45). However, this finding is controversial
because another study did not observe direct neuronal contact
with epithelial cells (46). Thus, further experiments need to
clarify the exact interaction between sensory neurons and
epithelial cells. Sensory neurons respond to a broad variety
of chemical and physical stimuli that can activate different
ion channels, such as transient receptor potential vanilloid
(TRPV1), transient receptor potential ankyrin 1 (TRPA1) and
transient receptor potential cation channel subfamily M member
8 (TRPM8) (18, 47). An important class of sensory neurons
are nociceptors that are able to detect noxious stimuli such
as heat, chemical and mechanical perturbations (48). The role
of nociceptors in sensing a broad variety of stimuli, and in
turn, regulating immunological functions has been proposed by
several studies (49–54). For example, sensing of type 2 cytokines,
such as Interleukin (IL)-4, IL-5, IL-13 directly activate sensory
neurons and promote chronic itch that is dependent on neuronal
IL-4Rα and JAK1 signaling (53). Interestingly, JAK inhibitors
improved chronic itch in patients, even after failure of state-
of-the-art immunosuppressive therapy and therefore represent
a novel treatment option for atopic dermatitis (53). In addition
to type 2 effector cytokines, the epithelial cell-derived alarmin,
thymic stromal lymphopoetin (TSLP), which is an important
initiator of type 2 immune responses, can activate TRPA1+
sensory neurons in the skin and induce itch behavior in mice
(50). Besides itch, also pain-sensitizations have been proposed to
be induced by bacterial products following direct activation of
nociceptor sensory neurons (49, 55). In fact, Nav1.8+ neurons
sense bacteria-derived N-formylated peptides and α-hemolysin
suggesting that pain can be a direct consequence of neuronal
sensing of bacteria during certain infections in addition to the
reaction to immune activation or inflammation (49). Meseguer
and colleagues found that lipopolysaccharide (LPS) was able
to directly stimulate excitatory actions on TRPA1+ neurons
and thus eliciting nociceptor activity and eventually pain (55).
The finding that bacteria directly induce pain-sensitizations is
intriguing because subclinical, not overt low grade infections
may be causative for different chronic pain syndromes in
humans. Thus, blocking of specific, bacteria-derived neuronal
sensitizations may be a valuable treatment option for such
chronic pain syndromes (56). These studies further unraveled
the potential of pathogen-sensing via the autonomous nervous
system that has classically been attributed to pathogen-receptors
expressed on immune cells. Therefore, the autonomous nervous
system may be an important player in the establishment of
host-microbial mutualism. Another fact that has not yet been
deeply addressed is the expression of classical pattern-recognition
receptors, such as toll-like receptors (TLRs) 2, 4, and 7 on enteric
neurons, which have been well-studied on myeloid and epithelial
cells (57, 58). If we consider the broad variety of existing TLR-
ligands, the ENS may therefore be an unprecedented player
in pathogen recognition. In fact, the ENS has recently been
shown to directly recognize parasite-derived excretory-secretory
products in a Myd88-dependent fashion during Nippostrongylus
brasiliensis (N. brasiliensis) infection in mice underlining the
concept of pathogen-sensing by the ENS (37). Furthermore,
viruses can stimulate different TLRs, thus broadening the
functional role of the ENS in mounting immune reactions
against infections (59, 60). However, there is a fundamental
lack in knowledge of how the ENS can sense these signals and
consequently adapt immune effector functions. While functional
studies investigating the role of TLRs in neurons are scarce,
several reports highlight the importance of TLRs in glial cells.
Deletion of the signaling adapter molecule MyD88 on glial cells,
which transduces signals of many TLRs but also IL-1 cytokine
receptors such as IL-1R, IL-33R, IL-18R, resulted in decreased
ILC activation during DSS colitis and N. brasiliensis infection
and suggests that there is TLR-mediated sensing of pathogens by
the ENS and vice versa leading to immune activation (37, 61).
Especially TLR2 seems to play an important role in controlling
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ENS architecture and consequently intestinal inflammation via
glial cell-derived neurotrophic factor (GDNF) (62). In fact,
enteric neurons from TLR2−/− mice had smaller ganglia, fewer
HuC/D+ and nNOS+ neurons as wells as shorter betaIII-
tubulin axonal networks, whereas supplementation with GDNF
corrected the observed phenotype (62). Nociceptors on the other
hand release neuropeptides, such as CGRP, substance P, and VIP,
which can adapt the local immune function depending on the
milieu and the local challenge. That neurons have the ability
to directly sense and integrate signals may also be represented
by the fact that the microbial colonization has an important
impact on neurophysiology and behavior (63, 64). In fact, germ-
free mice, which are devoid of any microbial exposure, develop
relevant alterations in behavior and the microbiota seem to
be relevant to different neurodegenerative diseases (65, 66). A
detailed discussion of the gut-brain axis is, however, beyond the
scope of this review and the reader is kindly referred to excellent
articles (64, 67).
THE ENTERIC NERVOUS SYSTEM
INTEGRATES SIGNALS FROM
COMMENSAL MICROBIOTA
The microbiota inhabit all mammalian body surfaces and
play a pivotal role in the education of the host immune
system (68). Recent evidence now suggests that the presence of
commensal microbiota also shape the neuronal gene programs
and eventually the extrinsic sympathetic activity (46, 69).
Muller and colleagues proposed that the commensal microbiota
shape intrinsic enteric-associated neuronal programs (EAN)
region-dependent along the intestine, whereas intrinsic EAN
are functionally adapted to the specific intestinal region
and its associated microbial challenge. Interestingly, germ-
free mice exhibited hyperactivation of sympathetic neurons
whereas the microbial product, butyrate, suppressed sympathetic
hyperactivation (46). These results reveal that a metabolite-
mediated gut-brain circuit adapt autonomic nervous functions
dependent on the local milieu. Because the sympathetic nervous
system controls different autonomic nervous functions (blood
pressure, heart rate and other) one may speculate that certain
human diseases may be caused by alterations in the intestinal
microbial composition. Furthermore, the aryl hydrocarbon
receptor (AhR) has been shown to be expressed by virtually
all myenteric neurons in the colon and the distal small
intestine in specific-pathogen-free (SPF)-colonized mice whereas
its expression was absent in the duodenum and jejunum of SPF-
colonized mice or in the colon of germ-free mice suggesting
that the microbial colonization dictates AhR expression. Enteric
neuron-specific deletion of AhR resulted in an increase in gut-
transit time whereas supplementation of the Ahr-ligand, I3C,
restored intestinal transit time suggesting that neuron-specific
and ligand-dependent activation of AhR controls intestinal
motility (69). Taken together, these studies reveal a link between
the intestinal microbiota and enteric neurons suggesting that
enteric neurons constantly sense the commensal microbiota in
order to maintaining body homeostasis.
CELLULAR MECHANISTICS OF
NEURO-IMMUNE INTERACTIONS
Innate Lymphoid Cells (ILCs)
ILCs enclose diverse populations of innate immune cells,
which are derived from the common lymphoid precursors,
but which lack rearranged antigen-specific receptors and thus
develop independently of Rag recombination (70, 71). Based
on developmental and functional aspects, two different main
groups of ILCs are distinguished, cytotoxic ILCs [conventional
natural killer (NK) cells] and helper-like ILCs (ILC 1, 2,
and 3) (72, 73). Conventional natural killer cells (NK cells)
are known since the 1970s because they are well-represented
in the blood and secondary lymphoid organs (74, 75). NK
cells are developmentally dependent on the transcription factor
Eomesodermin and mediate immunity to intracellular pathogens
and tumors. The immunology of helper-like ILCs was mainly
studied in the last 10 years (76) with the exception of lymphoid
organ development mediated by lymphoid tissue inducer cells
(LTi cells) (77). The reason for the late discovery has been
discussed (78) but one reason might be the enrichment of
helper-like ILCs at barrier surfaces, which were less in research
focus at that time. Helper-like ILCs are characterized based on
the expression of and developmentally dependency on lineage-
specifying transcription factors and the effector cytokine profile:
(i) ILC1s require T-bet and secrete IFN-γ and TNF and are
involved in control of mainly intracellular pathogens, (ii) ILC2s
require GATA-3 and BCL11b and secrete IL-5, IL-9, and IL-13 to
combat helminth infections or to drive allergic reactions, and (iii)
ILC3s are RORγt dependent IL-22 secreting cells, whichmaintain
barrier integrity and protect from intestinal infections. ILC3s can
be subdivided in CCR6+ LTi-like producing IL-17A and CCR6−
ILC3, which co-express T-bet and IFN-γ and have the potential to
differentiate into ILC1-like cells. For a more detailed overview on
ILCs biology the reader is kindly referred to more comprehensive
reviews on this is topic (76, 79, 80).
ILCs are mainly located at barrier surfaces and act as
a first line of defense against potentially invading microbes
and are establishing host-microbial interactions. In addition to
host-defense mechanisms, ILCs have also been implicated to
contribute to tissue repair and maintenance of barrier integrity
and organ homeostasis (81–84). In order to fulfill this function,
ILCs need to be rapidly activated. However, in contrast to
myeloid cells, the expression of pattern recognition receptors is
very limited in ILCs suggesting that they do not sense danger
signals directly by expression of pattern recognition receptors.
Instead, they are activated indirectly by cytokines secreted by
other cells in tissues, e.g. by alarmins and other cytokines such
as IL-12 and IL-15 for ILC1s, IL-25, IL-33, and TSLP for ILC2s,
IL-1β, IL-23, and TL1A for ILC3s (79, 85, 86).
Since ILCs are present in large numbers in the intestine, which
is also densely innervated by the ENS and the other components
of the autonomic nervous system, neuronal factors emerged
as potential regulators of immune responses and sensors for
danger signals. Indeed, recent research has provided evidence
that ILCs integrate neuronal signals and express receptors for
neuropeptides and neurotransmitters (Figure 3) (23, 36–42, 44,
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FIGURE 3 | The complex interactions of the enteric nervous system with innate and adaptive immune cells. (A) Representation of the close co-localization of extrinsic
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dendritic cell; Mφ, macrophage; ILC, innate lymphoid cell; γδT, gamma-delta T cell; α7nAChR, alpha7 nicotinic acetylcholine receptor; β2aR, beta2 adrenergic
receptor; VIP, vasoactive intestinal peptide; NMU, neuromedin U; CGRP, calcitonin-gene related peptide; VIPR2, vasoactive intestinal peptide receptor 2; NMUR1,
Neuronmedin U receptor 1.
87, 88). ILC responses are regulated by the ENS as well as the
sympathetic and parasympathetic nervous system, glial cells and
by endocrine loops (89).
The sympathetic arm and the respective neurotransmitter
norepinephrine has been shown to inhibit ILC2s and
consequently decrease type 2 responses via β2-adrenergic
receptors (Figure 3A). Absence of the β2-adrenergic receptor on
ILC2s in a mouse model of N. brasiliensis magnified the type 2
immune reaction and resulted in improved worm clearance (23).
Similar to the cholinergic anti-inflammatory pathway, regulation
of acetylcholine on ILC2s has been shown to bind on alpha7-
nicotinic acetylcholine receptors (α7nAChR) (Figure 3A).
Administration of a specific agonist for α7nAChR on ILC2s
reduced ILC2 effector function and eventually dampened allergic
lung inflammation (88). In contrast, vagotomy and lack of
acetylcholine results in a delayed resolution of Escherichia
coli infection via peritoneal ILC3 (90). Mechanistically,
abrogation of vagal neuropeptides functionally decreased
secretion of the immunoresolvent PCTR1 by peritoneal ILC3
whereas supplementation of either PCTR1 or ILC3 restored host
responses against E.coli. These results suggest that the cholinergic
modulation has a tissue protective role and shapes the ILC3
compartment to regulate tissue homeostasis (91). Furthermore,
signals from the vagal nerve regulate the formation of tertiary
lymphoid tissue during chronic inflammation (92). However,
how much LTi cells are involved as receivers of neuronal signals
in this process requires further investigation.
ILC3 are critical in host-defense at mucosal sites and
regulators in inflammation. Recent data show that adult
CCR6+ ILC3 express the neurotrophic receptor RET and ILC3-
autonomous RET ablation decreased IL-22 production and
increased the susceptibility to bowel inflammation and infection
suggesting a modulatory interaction of the nervous system
with ILC3 (61). Microbial sensing of the microenvironment
is mediated by glial cells adjacent to cryptopatches, in
which the CCR6+ ILC3s are located. Upon sensing of
microbial-associated molecular patterns, glial cells released the
RET-ligand glial cell-derived neurotrophic factor (GDNF) to
stimulate IL-22 production of CCR6+ ILC3s in the cryptopatch.
(61). Within intestinal tissues, ILCs and nerves show a
close co-localization, which presumably supports neuronal
regulation of ILC responses. Enteric neurons express the
neuropeptides NMU, VIP, and CGRP whereas the receptors
for these neuropeptides are expressed on ILCs (Figure 3B)
(37–44).
NMU is a highly conserved neuropeptide, which is generated
by proteolytic cleavage of a pro-protein by unknown proteases
into bioactive small peptide fragments (93). NMU is mainly
expressed in the thalamus in the CNS and enteric neurons
within the gastrointestinal tract. NMU binds to two large G-
protein coupled receptors, coined NMUR1 and NMUR2. While
NMUR2 is mainly expressed by neurons, NMUR1 was found to
be selectively expressed by ILC2s (Figure 3B) (37–39, 90, 93).
Furthermore, NMU was a very strong stimulator of ILC2s and
triggered type 2 immune responses promoting anti-helminth
immunity in the intestine or in the context of lung inflammation
via NMUR1 (37, 38). Interestingly, NMU was shown to be
upregulated during helminth infection and enteric neurons
were shown to directly sense worm-derived excretory/secretory
products in a Myd88-dependent manner and react to that stimuli
with the production of NMU as an immune effector molecule.
Altogether these data support a model where cholinergic neurons
regulate type 2 inflammation via production of NMU and
engagement of NMUR1 on ILC2s.
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While NMU from cholinergic neurons stimulate ILC2s,
the neuropeptide CGRP is also secreted by neurons with a
cholinergic signature but in contrast inhibits ILC2 activation
(Figure 3B). Interestingly, ILC2 also produce CGRP themselves
in addition to being equipped with the receptors for CGRP
CALCRL/Ramp1. Therefore, CGRP might act as a negative
feedback loop to control ILC2 activation. CALCRL/Ramp1
engagement by CGRP binding triggers a signaling cascade
in ILC2s, which signals via Gαs proteins and regulate
intracellular cAMP levels. ILC2 activation is suppressed by
CGRP and genetic deletion of components of the CGRP—
CALCRL pathway resulted in elevated ILC2s responsiveness
and type 2 inflammation in the context of helminth infection,
lung inflammation and food allergy (40–43). Other findings
uncovered the regulation of ILC2s by neuroendocrine cells (94)
and tuft cells that share many commonalities with neurons
(Chat-expression, sensing, signal transmission). Pulmonary
neuroendocrine cells on one hand secrete CGRP and GABA and
reside in close proximity to ILC2 in the lung. In models of allergic
asthma, neuroendocrine cells are pivotal players in regulating
ILC2s and consequently mucosal type 2 responses (94). Tuft cells
on the other hand are chemosensory cells in the intestine and
the major source of IL-25 and can activate ILC2 to mount type
2 responses (95–97). The commonalities of these cell types with
the nervous system however requires further investigation.
While Nmur1 was reported to be selectively expressed by
ILC2, Vipr2, one receptor for VIP, is expressed on both ILC2 and
ILC3 (Figure 3B). VIP, known as the circadian synchronizer, has
been shown to stimulate ILC2 via Vipr2 resulting in the release
of IL-5. (87). Nav1.8+ nociceptors in the lung secrete VIP upon
stimulation and the resulting induction of IL-5 has been linked to
eosinophil accumulation and consequently worsened ovalbumin-
induced lung inflammation (87). The ILC2-mediated production
of IL-5 further increased the nociceptor stimulation in the sense
of a backward loop (36). VIP can also adapt ILC3 function in the
intestine dependent on the day and oscillating between active and
resting phases (41). ILC3 expressed high levels of Vipr2 whereas
VIP induced the IL-22 production that has been shown to be
an important player in maintaining bowel integrity (98). In fact,
genetic deletion of the VIP-Vipr2 pathway by using Vipr2−/−
mice resulted in an increased susceptibility to DSS-colitis (41). A
study by Talbot and colleagues found that CCR6+ ILC3s but not
CCR6− ILC3s, in cryptopatches expressed Vipr2 and additional
molecules related to neuro-immune interaction. CCR6+ ILC3s
are an important source of IL-22, which regulates epithelial
function including production of antimicrobial peptides and
lipid absorption and thereby adapting the immune control
to nutrient uptake (44). While the VIP–VIPR2 pathway links
antimicrobial immunity, circadian rhythm and food adsorption,
whether ILC3 are stimulated or inhibited by VIP is controversial.
Seillet and colleagues measured that VIP induces ILC3s and IL-
22 production whereas Talbot et al. found inhibition of ILC3s and
IL-22 by VIP (41, 44). Therefore, further experiments need to be
conducted to investigate context-dependent effects of VIP.
The hypothalamic-pituitary-adrenal axis (HPA) regulates the
immune system via control of glucocorticoid secretion, which is
key negative regulator of hematopoetic cells. Although secreted
by the adrenal gland, the production of glucocorticoids is
under control of the CNS and, therefore, linked to neuronal
regulation of immune responses. Quatrini and colleagus
recently showed that the regulation of natural killer (NK) cell
function is dependent on the glucocorticoid receptor (GR) for
resistance to sepsis and for immunopathology in the context of
murine cytomegaly virus infection. Mechanistically, endogenous
glucocorticoids induced the expression of PD-1 on NK cells and
limited the production of IFN-G eventually preventing mortality
in infected mice (99, 100). These results highlight the importance
of further studies that investigate the functional role of the HPA
axis in tuning or downregulating immune functions.
In summary, neuronal regulation of ILCs via multiple
neuropeptides and neurotransmitters and the corresponding
receptors expressed by ILCs, emerged as an important signaling
hub in tissues for integration of body homeostasis and immunity
at barrier surfaces.
Dendritic Cells
Dendritic cells (DC) are classical antigen-presenting cells that
express pattern recognition receptor (PRRs) to sense the
environment for the presence of danger signals and if necessary
initiate an immune response against the pathogenic encounter.
In addition to PRRs, DCs express adrenergic receptors and
receptors for neuropeptides suggesting a modulative effect
of the autonomous nervous system in mounting immune
responses (22). In fact, β2-adrenergic stimulation of DCs
results in skewing the T cell response toward Th2 and Th17
responses at the costs of Th1 promotion (Figure 3A) (22).
However, conclusions drawn from these findings are limited
because experiments, which demonstrate the importance of DC-
neuron interaction via β2-adrenergic receptors in vivo are still
missing (25).
The interaction of neurons and DCs has recently been
highlighted in the skin in the context of Candida albicans (C.
albicans) infections and Psoriasis-like inflammation (51, 52).
Nociceptive signals by C. albicans in the skin can directly
induce the secretion of CGRP. Such stimuli lead to the
production of IL-23 by DCs further resulting in activation of
GδT cells and secretion of IL-17A (Figure 3B). Notably, the
absence of sensory neurons increased the susceptibility to C.
albicans infections suggesting that neurons sense pathogens
in order to control infections in close interaction with DCs
(52). Another study showed that DCs are in close contact
to nociceptive neurons and express the ion channels TRPV1
and Nav1.8 in the skin. Ablation of nociceptors led to
failure of IL-23 production by DCs and consequently did
not induce inflammatory cytokine production by GδT cells.
Interruption of this neuro-immune cue failed to recruit
inflammatory cells upon infection suggesting that TRPV1+
Nav1.8+ nociceptors regulate the IL-23/IL-17 pathway and
control cutaneous immune responses (51). These experiments
suggest a clear link between the neuro-DC interaction and
skin disease pathogenesis. However, the expression of a broad
variety of receptors for neuropeptides/neurotransmitters on
DCs remains a blackbox and studies need to delineate the
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role of the DC-neuron interaction in steady-state and other
disease models.
Neutrophils
Neutrophils express and release a large variety of cytokines to
regulate inflammatory reactions, and to recruit and activate other
cells of the immune system. In addition, they have the ability for
engulfment and intracellular killing and thus are players at the
front-line of defense against invading pathogens (101). Because
these cells act at the fore-front of tissue damage, the neuronal
signalingmay be obvious because of the urgency of infections and
the need for cell recruitment.
In the context of Streptococcus pyogenes infection in the
skin, bacteria can directly activate nociceptive neurons via
secretion of streptolysin S. Activation of nociceptors resulted
in the release of the neuropeptide CGRP that inhibited the
recruitment of neutrophils and phagocytic killing that can
be seen as a hide-me signal of bacteria (Figure 3B) (56).
Interestingly, Botulinum neurotoxin A and CGRP antagonists
reversed the suppressed immune-reaction suggesting that this
may be a valuable strategy to overcome the pathogenicity
of highly invasive bacterial infections. In line with this
data and in a model of Staphylococcus aureus pneumonia,
TRPV1+ nociceptors suppressed the recruitment of neutrophils
and altered GδT cells whereas this inflammatory suppression
worsened survival, cytokine production and bacterial clearance
(54). Another study that highlights the role of neuronal-
neutrophil crosstalk has shown that noradrenalin suppressed
chemotaxis and phagocytosis in a stroke model (Figure 3A) (24).
Taken together, there is good evidence that neuronal sensing
of microbes shapes immune responses at barrier surfaces such
as the skin and the lung. However, there is a fundamental lack
of knowledge on the complex interaction of neurotransmitters
and neuropeptides at other barrier surfaces such as the intestine.
For example, because the receptor for CGRP CALCRL/Ramp1
is relatively broadly expressed on immune cells, future studies
need to address if the adaptation of neutrophil function is a rather
direct effect mounted by CGRP itself or an indirect effect through
functional changes of other cells. A direct effect of neurons on
neutrophil function would be intriguing because it could explain
rapid cell recruitment during inflammation. However, further
studies need to address the expression and function of specific
neuropeptide or neurotransmitter receptors on neutrophils.
Macrophages
Macrophages are specialized phagocytes that are located in
most body tissues. As a part of the innate immune system,
macrophages help keeping the organism clean and restore tissue
damage. Thus, they process dead cells, debris, foreign bodies,
and initiate inflammatory processes via antigen-presentation.
The expression pattern of receptors for neuropeptides and
neurotransmitters on macrophages suggests that neurons and
macrophages are closely linked in order to regulate tissue
homeostasis and to fight infections.
The pivotal role of macrophages in integrating cholinergic
signals resulting in a profound anti-inflammatory effect has
been shown by the group of Tracey, which has been termed
the “cholinergic anti-inflammatory pathway” (Figure 3A)
(102). The initial observation that vagus nerve stimulation
prevented the development of septic shock in mice implies
neuronal control of macrophage function in acute disease
(11). Later on, the group of Tracey discovered that vagal
signals are transmitted via acetylcholine that binds α7 nicotinic
acetylcholine receptors (α7nAChR) expressed on macrophages
and results in dampening of TNF production (102). If we
consider the speed of neuronal conductance, central stimuli are
capable of instantaneous cell recruitment and modulatory signals
to the site of inflammation (8). Another example of cholinergic
vagal control of inflammation via macrophages has been shown
in a model of postoperative ileus. The α7nAChR was expressed
on muscularis macrophages and controlled postoperative ileus
formation whereas stimulation of the vagal nerve attenuated
surgery-induced intestinal inflammation (103). The interplay
and the tight connection of macrophages located within the
longitudinal and circular muscle layer in close contact with the
myenteric plexus (Figure 2) not only controls postoperative
ileus formation, but is also involved in the pathogenesis of
diabetic-induced gastroparesis (104). There are clear parallels
between the autonomous nervous-macrophage interaction in
the periphery and the interaction of tissue-resident macrophages
within the CNS (105). This close proximity of biologic functions
in different tissues has been suggested because neuronal signals
in the CNS keep tissue-resident macrophages at a quiescent state
and macrophages in the CNS express high levels of CX3CR1,
a pattern that has been postulated to be unique for tissue
resident-macrophages in the CNS, the microglia (105).
In the intestine, the growth factor for macrophage
development, colony stimulatory factor 1 (CSF1), is secreted
by the nervous system and controls gastrointestinal motility.
Reciprocally, macrophages sense the microbiota and change the
pattern of smooth muscle contractions via bone morphogenic
protein 2 (BMP2) binding on the BMP receptor expressed
on enteric neurons (Figure 3B) (106). These results suggest a
reciprocal tight regulation of gastrointestinal motility via the
interaction of muscularis macrophages and enteric neurons that
in turn depend on signal input from the intestinal microbiota.
The anatomic location of intestinal macrophages is highly
specialized dependent on the proximity to the gut-lumen.
In fact, lamina propria macrophages represent a rather pro-
inflammatory phenotype in comparison to macrophages located
in the muscularis that represent a rather tissue-protective
phenotype. Extrinsic sympathetic neurons mediate tissue-
protective effects via activation of β2-adrenergic receptors
expressed on macrophages in the muscular sheet (Figure 3A)
(21). Furthermore, intestinal muscularis macrophages
protect neurons from cell-death via β2-adrenergic mediated
upregulation of neuroprotective programs (107). Taken together,
macrophage function is highly dependent on the signal input
from the autonomous nervous system and vice versa to rapidly
react to infectious stimuli and tissue damage.
Mast Cells
Urticaria, a common psycho-dermatological disorder, is the
result of vascular dilation, edema, and the immediate release of
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histamine by mast cells in the skin (108). It has been suggested
that psychological stress is strongly involved in the pathogenesis
of urticaria underlining the role of neuronal triggers to effector
cells such as mast cells (109). Throughout the gastrointestinal
tract, mast cells are located in close proximity to sensory nerve
fibers (110). Mast cells contain granules rich in histamine and
heparin, which can be immediately released and trigger rapid
responses such as allergic reactions or anaphylaxis.
Mast cells have also been implicated in atopic dermatitis,
where dermal lesions are hyper-innervated with a high
abundance of substance P fibers and an increased respective
receptor expression on mast cells (111). Nerve-derived substance
P induced the rapid release of histamine, TNF, leukotriene B4,
and vascular endothelial growth factor by mast cells suggesting
a close interaction of neurons and mast cells in allergic diseases
(18, 112, 113). This neuronal-mast cell connection has been
underlined in the context of allergic skin disease models in
mice. House dust mites directly activated TRPV1+ nociceptive
sensory neurons driving the development of allergic skin
inflammation via the secretion of substance P that eventually
resulted in degranulation of mast cells (113). This data provides
an important signaling pathway that may be the mechanistical
basis for a broad variety of allergic diseases. Psychological stress
additionally triggers the release of neuropeptides (Substance P,
Corticotropin Releasing Hormone) that act on mast cells and
promote the release of mast cell mediators (114). Interestingly,
mast cells but not eosinophils or T-cells were associated with
asthmatic diseases in patients underlining the importance of
these cells for allergy development in humans (115).
T- and B-Cells
Autonomous nervous fibers innervate lymphoid organs such
as mesenteric lymph nodes and Peyer’s patches (116, 117).
There is evidence that lymph nodes may receive neural
afferent innervation in addition to the sympathetic efferent
innervation that may suggest neuronal sensing of imminent
immunologic threats whereas such coordinated actions direct
the immune system to sites of injury and infection (118,
119). The close proximity to adaptive immune cells suggests
that nerve fibers participate in neuro-immune cross-talk and
modulate signals from the adaptive immune system. Sympathetic
neurotransmitters such as epinephrine and norepinephrine
predominantly bind β2-adrenergic receptors that are highly
expressed on B cells and to a lower level in CD4+ T cells
(Figure 3A) (20). Activation of β2-adrenergic receptors in
general increase intracellular cAMP that activates protein kinase
A. Such activation of the B-cell compartment via β2-adrenergic
receptors seems to be needed for maintenance of an optimal
antibody response suggesting that the autonomous nervous
system controls and shapes the magnitude of immune responses
(120). In line with the effects observed in B-cells, T cells and the
release of their effector cytokines are controlled via sympathetic
activity whereas sympathetic innervation suppresses Th1 and
promotes Th2, Th17 and Treg responses (20, 25). Another
finding that supports the notion that the autonomous nervous
system controls adaptive immune functions and recruits cells
to effector sites is that activation of β2-adrenergic receptors
enhanced retention-promoting signals and inhibited lymphocyte
egress from lymph nodes (121). Such migratory effects are
dependent on circadian regulation in the T-cell compartment
suggesting that the magnitude of adaptive immune responses
can depend on neuronal-regulated signaling input from the
CNS (122). It should be noted that the β2-adrenergic receptor
was reported to control ILC2 and macrophage activation. Thus,
further experiments need to clarify if the modulation of T-cell
function is rather a consequence of the release of cytokines
by other cells or delineate the exact downstream effects upon
β2-adrenergic receptor activation in steady-state and disease.
NEURO-IMMUNE INTERACTIONS IN
DISEASE
Inflammatory Bowel Disease
Psychologic disorders show a lifetime prevalence of up to 30%
in the general population and major depression may become
the most important disease in Western societies (123, 124). In
line with the constant increase of psychologic disorders, the
incidence of IBD increase as well emerging an unprecedented link
between a potential nervous dysregulation and overwhelming
immune activation (125). In fact, many patients with IBD have
alexithymia that is characterized by the impossibility to verbalize
emotions. Such endogenous stress may interfere with body
homeostasis and lead to a distorted integrity of the neuro-
immune axis that may be causative or at least worsen the
clinical course of IBD (126). In mouse models, catecholamines
acting on α2-adrenoreceptors led to pro-inflammatory cytokine
production worsening dextran sodium sulfate (DSS) colitis.
Paradoxically, sympathetic denervation induced clinical signs
of colitis (Figure 4A) (127, 128). In vitro experiments have
shown that norepinephrine blocks the secretion of a variety
of proinflammatory cytokines and mice lacking the beta-2-
adrenergic receptor were more susceptible to DSS-colitis (129).
These studies reveal that sympathetic innervation can have
pro- and anti-inflammatory effects and studies need to further
clarify its role in IBD. In fact, a retrospective study in humans
by using pharmacological inhibition of β-adrenergic receptors
showed higher risk for IBD relapse suggesting that solely
blocking the pro-inflammatory effect of sympathetic activation
may have rather pro-inflammatory effects in long term (130). The
parasympathetic tone via the vagal nerve also impedes with IBD.
Studies in vagotomised mice showed increased susceptibility
to develop colitis upon DSS treatment similar to the anti-
inflammatory reflex observed in models of septic shock (131,
132). The absence of the vagal tone was associated with an
increase in pro-inflammatory cytokines such as IL-1β, IL-
6, and TNF (Figure 4A). These cholinergic signals seem to
be transmitted via α7nAChR (131). Apart from the α7nACh
receptor, also α5nAChR knockout mice had more severe colitis
suggesting that vagal innervation acts in different acetylcholine
receptor subunits and modulates immune functions (133). As
mentioned above, the psychological distress profile of IBD
patients focused the interest on the finding that mucosal levels
of acetylcholine in a murine model of depression were associated
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FIGURE 4 | Involvement of the autonomous nervous system in the pathogenesis of inflammatory bowel disease (IBD) and available treatment modalities that harness
neuro-immune interactions. (A) Stress and the transmitted signals may enhance the sympathetic tone and lead to an additional pro-inflammatory reaction in the
intestine that may be causal or at least worsening the course of IBD. Failure to maintain an adequate parasympathetic tone can further support the pro-inflammatory
reaction. (B) Available treatment options in chronic inflammatory conditions include electric stimulation of the vagal nerve in rheumatoid arthritis, IBD and
endotoxin-induced septic shock. Furthermore, the repertoire of treatment strategies for IBD and rheumatoid arthritis may be extended with α7nAChR-agonists.
β-blockade should, however, be omitted in IBD. α7nAChR, alpha7 nicotinic acetylcholine receptor; α5nAChR, alpha5 nicotinic acetylcholine receptor; α2aR, alpha2
receptor; β2aR, beta-2 adrenergic receptor; TNF, tumor necrosis factor alpha.
with more severe colitis in response to DSS suggesting that
chronic modulation of the vagal tone enhances the susceptibility
to IBD (132). Interestingly, adoptive transfer of macrophages
from depressive mice induced inflammatory markers and
increased the severity of DSS colitis. These data identified the
pivotal role of macrophage in linking stress and susceptibility
to intestinal inflammation whereas this effect was reversible
with antidepressants (Figures 4A,B) (134). Apart from the
importance ofmacrophages as effector cells of the neuro-immune
axis, transfer of CD4+ T cells isolated from vagotomised animals
resulted in an increased susceptibility to DSS colitis suggesting
that more players are involved in cholinergic signal transmission
underlining the need to study this interaction in more detail
(135). Taken together, the sympathetic and parasympathetic
nervous system play important roles in mounting pro- and anti-
inflammatory immune reactions in the context of IBD. As a
potential therapeutic target in a preclinical model of colitis, the
α7nAChR agonist anabaseine, showed considerable effect and
the mice developed less weight loss and less severe colitis in
a DSS colitis model (Figure 4B) (136). Other reports showed
opposite results. Although α7nAChR agonists reduced NF-κB
transcriptional activity, IL-6 and TNF release, α7nAChR agonists
worsened the effects of DSS-induced colitis or were ineffective
in a model of TNBS-induced colitis (137). It is in addition of
importance to emphasize that anti-inflammatory effects may
lead to an increased susceptibility to infectious diseases (8).
Following bacterial peritonitis, virtually all α7nAChR knock-out
mice cleared the infection from their peritoneal cavities and
had sterile blood cultures mediated via neutrophil recruitment,
whereas wild type mice had high bacterial loads at the primary
site of infection and were bacteremic (138). These data underline
the potential importance of the α7nAChR in host defense. In
line with this observations, acetyl-cholinergic agonists, such
as nicotine, worsened bacterial clearance and survival upon
abdominal sepsis (139, 140). Thus, translation into the clinical
setting has to be obtained with caution because solely dampening
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effector immune function and consequently immune suppression
may lead to serious infectious complications. Another interesting
approach for the treatment of IBD is the direct electric
stimulation of the vagal nerve via an implantable device targeting
the anti-inflammatory pathway (Figure 4B). First results have
shown improvement in disease activity and endoscopic indices
in patients following electric stimulation of the vagal-nerve (141).
These results are promising because treatment failure of available
biologics is not uncommon and effective treatment is associated
with considerable side-effects and mortality in the long term
(142). A deeper understanding is needed andmay help to uncover
novel therapeutic measures for treating IBD. Of note, depression
and other psychological disorders may enhance the disease
severity and either antidepressive medication or psychological
co-therapy may adjust immune functions and lower the severity
of the clinical course.
Furthermore, it is of importance to note that enteric glia
cells, specialized macrophages in close proximity to neurons,
outnumber neurons by 4- to 10-fold (Figure 2) (143). The pivotal
role of glial cells in neuro-immune interactions was observed
after ablation of enteric glia cells that led to fulminant jejuno-
ileitis in mice (144). Enteric glial cells express a broad pattern
of neurotransmitters and thereby protect neurons and regulate
their activity (145). Enteric glial cells show abnormal behavior in
IBD in humans but their role in its pathophysiology has to be
further clarified.
Ileus
Postoperative Ileus is a serious concern in the surgical
setting because patients fail to rapidly recover from an
operative intervention and remain with symptoms such as
nausea, vomiting, and constipation. Following a surgical
procedure, postoperative ileus formation is characterized by an
over-activation of inhibitory neuronal pathways that triggers
inflammation beyond the distant untouched areas and leads to
generalized impairment of gastrointestinal motility (146). In fact,
low-grade inflammation due to macrophages residing in the
intestinal muscularis is key in the induction of postoperative
and endotoxin-induced ileus formation (147, 148). Activation
of these macrophages mediated the influx of leucocytes at 3–4
days after surgery whereas the inflammatory response impaired
normal propulsive neuromuscular function and consequently
digestion (146). There is an urgent need to uncover novel
pharmacologic targets in the early event of microscopic
inflammation that may help to reduce ileus formation. Studies
show that ileus onset can be reduced by modulating the
cholinergic anti-inflammatory tone (149–151). Interestingly,
vagal stimulation reduced surgery-induced inflammation and
ameliorated postoperative ileus formation in a STAT3 dependent
manner mediated by intestinal macrophages (149). Supportive
literature showed that modulation of cholinergic neurons
via α7nAChR agonists improved gastrointestinal transit time
through inhibition of low-grade inflammation on the basis of
macrophages (150, 151).
Sepsis
The cholinergic anti-inflammatory function via dampening of
TNF synthesis has been shown in LPS-induced endotoxemia,
whereas stimulation of the vagus nerve protected from
the development of shock (11) (Figure 4B). Interestingly,
splenectomy abolished the anti-inflammatory effect of the
vagal nerve suggesting a pivotal role of the spleen in
inflammatory reactions. This observation may explain why
the organism is prone to the often fatal overwhelming post-
splenectomy syndrome (OPSI) that may serve as an alternative
hypothesis to the current thinking that OPSI is a result of
impaired clearance of encapsulated bacteria (152). Advances
in the mechanistic understanding of this observed phenotype
exposed that acetylcholine signals via the α7 subunit of the
acetylcholine receptor expressed on macrophages that controlled
systemic TNF release (153). Since nerve fibers in the spleen
lack the enzymatic machinery for acetylcholine production,
systemic inflammation recruits vagus-primed T cells from
the intestine to the spleen, which produce acetylcholine and
mount the innate immune response (154). Other data suggest
that the anti-inflammatory properties of cholinergic neurons
also attenuate inflammation and injury during experimental
pancreatitis and hepatitis (155, 156). In a mouse model of
pancreatitis, pretreatment with the nicotinic receptor antagonist
mecamylamine resulted in more severe pancreatitis increasing
edema, plasma hydrolases, and IL-6 levels. Conversely pre-
treatment with the selective α7nAChR agonist anabaseine
strongly decreased the severity of pancreatitis suggesting that
there may be a therapeutic role of the “cholinergic anti-
inflammatory pathway” in the treatment of acute pancreatitis in
order to attenuate inflammation and injury (155). As a matter of
fact that cholinergic neurons have a systemic anti-inflammatory
effect, vagotomy increased mortality in mice upon Fas-induced
hepatitis whereas pretreatment with nicotine or α7nAChR
agonist, inhibited this detrimental effect of vagotomy and rescued
the mice (156).
Rheumatoid Arthritis
Rheumatoid arthritis is the most common inflammatory arthritis
and affects up to 1.25% of the entire population (157).
The pathogenesis is multidimensional and includes a genetic
predisposition in addition to environmental challenges leading
to synovial inflammation and eventually resulting in bone
erosions, cartilage damage and eventually joint deformities and
disabilities (158). Recent advances in the understanding of
autoimmune diseases such as rheumatoid arthritis uncovered
a pivotal role of the autonomous nervous system in disease
pathogenesis (159). It has been shown that treatment with
α7nAChR agonist improved arthritis scores in animal models of
rheumatoid arthritis whereas α7nAChR knock-out mice showed
worse disease outcome suggesting its therapeutic potential
(Figure 4B) (160, 161). In fact, work provided by Koopmann and
colleagues showed that electric stimulation via an implantable
vagus nerve-stimulating device inhibits the production of TNF,
IL-1β, and IL-6 and improved clinical scores of rheumatoid
arthritis in patients (9). Together with similar data obtained in
asthmatic patients, this study provides a proof-of-concept that
treatment via activation of the cholinergic anti-inflammatory
pathway is effective and may translate into the regular
clinical setting.
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SUMMARY AND FUTURE PERSPECTIVE
Preclinical studies targeting neuro-immune interactions
upon stimulation of the vagus nerve, application of
acetylcholine agonist, and β2 adrenoreceptor agonists
have emerged the potential successful treatment in
inflammatory diseases (155, 162, 163). Of note, the site
specific control of immune functions by the nervous system
via neurotransmitters/neuropeptides suggest that the nervous
system can exert a rapid and local control of immune cells.
Unlike the systemic effects of cytokines, neuronal regulation of
immune responses allows for the selective and spatiotemporal
control of immune functions without affecting the activity of
distant cells. Based on this assumption, targeting neuro-immne
interactions might allow for specific and targeted therapy at a
cellular and compartmental level. The therapeutic potential of
neuronal modulation of inflammation in humans was already
demonstrated by stimulating the vagal nerve with electronic
devices that has been successfully used for the treatment of
rheumatoid arthritis and asthma (9, 164). Of note, some patients
did no longer respond to a conventional anti-inflammatory
treatment but developed disease improvement upon vagal
nerve stimulation (9). Another pilot study showed the efficacy
of vagal nerve stimulation in patients with Crohn’s disease
whereas its stimulation improved inflammatory parameters
and clinical symptoms (141). This work provides a rationale
for the potential of modulating neuro-immune interactions
and shows promising results reflecting that vagal-nerve
stimulation may be an alternative to pharmacological therapies.
This observation is further supported by a clinical study
that has shown asthma improvement during non-invasive
vagal nerve stimulation (164). Current study enrolments of
patients with a broad variety of diseases highlight the particular
interest in neuro-immune interactions [Post-surgery Systemic
Inflammation and Neuro-immune Interactions (POSINI)
NCT03055325, Vagal Nerve Stimulation for Gastroparesis
(VNS) NCT0312 NCT03908073, Transcutaneous VNS
to Treat Pediatric IBD (STIMIBD) NCT03863704]. The
increase of chronic inflammatory diseases in Western societies
with a significant amount of non-responders to current
treatment strategies underlines the need to uncover novel
strategies/medications. Therefore, it is crucial to improve our
understanding of how neurons interact with immune cells.
Recent technical advances, such as the RiboTag system, imaging
tools, genetic mouse models built the rationale to mechanistically
understand neuronal-immune circuits in more detail and
further uncover signaling pathways that could be therapeutically
harnessed (165–168).
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